CVS Health Corporation (NYSE:CVS) Q2 2024 Earnings Conference Call August 7, 2024 8:00 AM ET
Company Participants
Karen Lynch - President, Chief Executive Officer
Tom Cowhey - Executive Vice President, Chief Financial Officer
Prem Shah - Executive Vice President, Chief Pharmacy Officer
David Joyner - Executive Vice President, CVS Health
Larry McGrath - Senior Vice President, Investor Relations
Conference Call Participants
Lisa Gill - JP Morgan
Justin Lake - Wolfe Research
Stephen Baxter - Wells Fargo
Ann Hynes - Mizuho
Eric Percher - Nephron Research
Michael Cherny - Leerink Partners
Elizabeth Anderson - Evercore ISI
Kevin Caliendo - UBS
Lance Wilkes - Bernstein
Charles Rhyee - TD Cowen
Brian Tanquilut - Jefferies
Operator
Good morning or good afternoon all and welcome to the CVS Health Q2 2024 earnings conference call. My name is Adam and I’ll be your Operator today.
If you’d like to ask a question at the Q&A portion of today’s call, you may do so by pressing star followed by one on your telephone keypad.
I will now hand the floor to Larry McGrath to begin. Larry, please go ahead when you’re ready.
Larry McGrath
Good morning and welcome to the CVS Health second quarter 2024 earnings call and webcast. I’m Larry McGrath, Senior Vice President of Business Development and Investor Relations for CVS Health. I’m joined this morning by Karen Lynch, President and Chief Executive Officer, and Tom Cowhey, Chief Financial Officer. Following our prepared remarks, we’ll host a question and answer session that will include additional members of our leadership team.
Our press release and slide presentation have been posted to our website along with our Form 10-Q filed this morning with the SEC. Today’s call is also being broadcast on our website, where it will be archived for one year.
During this call, we’ll make certain forward-looking statements. Our forward-looking statements are subject to significant risks and uncertainties that could cause actual results to differ materially from currently projected results. We strongly encourage you to review the reports we file with the SEC regarding these risks and uncertainties, in particular those that are described in the cautionary statements concerning forward-looking statements and risk factors in our most recent annual report filed on Form 10-K, our quarterly report on Form 10-Q filed this morning, and our recent filings on Form 8-K, including this morning’s earnings press release.
During this call, we’ll use non-GAAP measures when talking about the company’s financial performance and financial condition, and you can find a reconciliation of these non-GAAP measures in this morning’s press release and in the reconciliation documents posted to the Investor Relations portion of our website.